| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 132,741 | 129,622 | 131,555 | 121,213 | | Cost of Revenue | (8,124) | 97,868 | 97,338 | 89,306 | | | Gross Profit | 140,865 | 31,754 | 34,217 | 31,907 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 120,917 | 11,773 | 11,420 | 11,079 | | Non Recurring | 702 | 1,945 | 2,584 | 2,526 | | Others | 8,267 | 7,888 | 7,495 | 6,902 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,690 | 10,148 | 12,718 | 11,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (910) | 413 | 76 | (126) | | Earnings Before Interest And Taxes | 10,069 | 10,561 | 12,794 | 11,274 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 10,069 | 10,561 | 12,794 | 11,274 | | Income Tax Expense | 3,197 | 3,586 | 4,308 | 3,547 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,872 | 6,975 | 8,486 | 7,727 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,872 | 6,975 | 8,486 | 7,727 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,872 | $6,975 | $8,486 | $7,727 |
|
0.01% Nasdaq 
0.22%
Income Statement
